Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia

被引:16
作者
Lee, JH
Lee, KH
Choi, SJ
Min, YJ
Kim, JG
Kim, S
Lee, JS
Kim, SH
Park, CJ
Chi, HS
Kim, WK
机构
[1] Univ Ulsan, Coll Med, Dept Med, Asan Med Ctr,Songpa Ku, Seoul 138040, South Korea
[2] Univ Ulsan, Coll Med, Dept Clin Pathol, Asan Med Ctr, Seoul 138040, South Korea
关键词
VOD; allogeneic BMT; SAA;
D O I
10.1038/sj.bmt.1702583
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
There are few reports about the occurrence of hepatic VOD after BRIT for severe aplastic anemia (SAA). We prospectively studied 17 patients with SAA after allogeneic BMT for the occurrence and severity of VOD, Plasma levels of protein C, protein S, antithrombin UI, VWF, t-PA and PAI-1 were determined before preparative chemotherapy, on the day of marrow infusion, and on days 7, 14 and 21, VOD occurred in seven patients (41.2%) at a median of day 1 (range, day -2 to 15), Five had mild, and two moderate VOD, Platelet transfusion requirements were higher in the patients with VOD, The plasma levels of natural anticoagulants such as protein C, free protein S and antithrombin III decreased significantly on day 0 from the baseline levels. Plasma levels of t-PA, PAI-1 and VWF increased significantly in the early post-transplant period compared to the baseline levels. The mean plasma levels of t-PA on day 7 (P = 0.016) and PAI-1 on days 0 and 7 (P = 0.016, 0.032) were higher in the patients with VOD, In summary, we observed hypercoagulability and a high incidence of VOD after allogeneic BRIT for SAA, Levels of t-PA and PAI-1 were significantly higher in the patients with VOD after BMT.
引用
收藏
页码:657 / 662
页数:6
相关论文
共 26 条
[11]   Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study [J].
Lee, JH ;
Lee, KH ;
Kim, S ;
Lee, JS ;
Kim, WK ;
Park, CJ ;
Chi, HS ;
Kim, SH .
BONE MARROW TRANSPLANTATION, 1998, 22 (09) :883-888
[12]   PREDICTABILITY BEFORE TRANSPLANT OF HEPATIC COMPLICATIONS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].
LOCASCIULLI, A ;
BACIGALUPO, A ;
ALBERTI, A ;
VANLINT, MT ;
UDERZO, C ;
MARMONT, AM ;
SHULMAN, HM ;
PORTMANN, B .
TRANSPLANTATION, 1989, 48 (01) :68-72
[13]   VENOOCCLUSIVE DISEASE OF THE LIVER AND MULTIORGAN FAILURE AFTER BONE-MARROW TRANSPLANTATION - A COHORT STUDY OF 355 PATIENTS [J].
MCDONALD, GB ;
HINDS, MS ;
FISHER, LD ;
SCHOCH, HG ;
WOLFORD, JL ;
BANAJI, M ;
HARDIN, BJ ;
SHULMAN, HM ;
CLIFT, RA .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (04) :255-267
[14]  
MODZELEWSKI JR, 1994, MODERN PATHOL, V7, P967
[15]  
RIO B, 1986, BLOOD, V67, P1773
[16]   Unusual complications after bone marrow transplantation for dyskeratosis congenita [J].
Rocha, V ;
Devergie, A ;
Socié, G ;
Ribaud, P ;
Espérou, H ;
Parquet, N ;
Gluckman, E .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (01) :243-248
[17]  
Rozman C, 1996, BONE MARROW TRANSPL, V17, P75
[18]  
SALAT C, 1994, BONE MARROW TRANSPL, V14, P747
[19]   Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation [J].
Salat, C ;
Holler, E ;
Kolb, HJ ;
Reinhardt, B ;
Pihusch, R ;
Wilmanns, W ;
Hiller, E .
BLOOD, 1997, 89 (06) :2184-2188
[20]  
SHULMAN HM, 1992, BONE MARROW TRANSPL, V10, P197